US 12404337
Compositions, doses, and methods for treatment of thyroid eye disease
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 12404337 (Compositions, doses, and methods for treatment of thyroid eye disease) held by Viridian Therapeutics, Inc. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Viridian Therapeutics, Inc.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K2039/55